A health worker prepares a dose of the Johnson & Johnson Covid-19 jab at a vaccination site in Philadelphia, US. File photo: AP
Coronavirus: manufacturing error at plant affects 15 million doses of Johnson & Johnson’s vaccine
- The company said a batch of drug substance failed its quality test at a Baltimore Emergent BioSolutions facility
- Johnson & Johnson said it reported the issue to the Food and Drug Administration
Topic |
Coronavirus pandemic
A health worker prepares a dose of the Johnson & Johnson Covid-19 jab at a vaccination site in Philadelphia, US. File photo: AP